our Premium Content: News alerts, weekly reports and conference planners
GENE:
RBM24 (RNA Binding Motif Protein 24)
i
Other names: RBM24, RNA Binding Motif Protein 24, DJ259A10.1, RNPC6, RNA-Binding Region (RNP1, RRM) Containing 6, RNA-Binding Region-Containing Protein 6, RNA-Binding Protein 24, FLJ30829, RNA-Binding Motif Protein 24
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Elevated levels of cuproptosis-induced cell death disrupt the MAPK signaling cascade, thus suppressing the metastasis of CRC. This discovery sheds new light on the potential application of cuproptosis in oncological treatments.
Expression heterogeneity of epigenetic regulators is closely associated with molecular subgroups and clinical outcomes in medulloblastoma. These findings highlight the role of epigenetic dysregulation in RNA metabolism and tumor progression, particularly in SHH-driven proliferative cells.
Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53- p66shc pathway...PMID: 33577026. The Publisher apologizes for any inconvenience this may cause.
More notably, we found that RBM24 binds to lncRNAs in addition to pre-mRNAs. These results indicated that RBM24 could play a key role in cancer progression by finding clinical therapeutic targets for Oral squamous cell carcinoma.
Our results demonstrate the value of consideration of RBP in the diagnosis and prognosis for HNSCC and provide a novel insight into understanding the potential role of dysregulated RBP in HNSCC.
over 1 year ago
Journal • PARP Biomarker
|
DNMT3B (DNA Methyltransferase 3 Beta) • IGF2BP1 (Insulin Like Growth Factor 2 MRNA Binding Protein 1) • AFF3 (AF4/FMR2 Family Member 3) • EIF5A2 (Eukaryotic Translation Initiation Factor 5A2) • RBM24 (RNA Binding Motif Protein 24)
There was also correlation between RBM24 and LATS1 protein expression in the xenograft tumors. RBM24 functions to stabilize LATS1 mRNA, thereby inhibiting the proliferation, suppressing invasion, and promoting apoptosis in GBM cells.
Collectively, the YAP1/RBM24/β-catenin axis plays a critical role in driving TNBC progression. RBM24 may represent a novel therapeutic target for TNBC treatment.
Moreover, Tpm1.8/9 expression confers resistance to taxane- and platinum-based chemotherapy. Small molecule inhibitors that target the Tpm1 isoforms support targeting Tpm1.8/9 as therapeutic targets for the development of future tailor-made clinical interventions.
2 years ago
Journal • Metastases
|
ESRP1 (Epithelial Splicing Regulatory Protein 1) • RBM24 (RNA Binding Motif Protein 24)
• miR-19a-5p targets RBM24, thus reducing the binding of RBM24 and AXIN1 and inhibiting AXIN1 transcription. • METTL14 silencing in vivo enhances the suppressive role of DDP to tumor growth.
the role of RBPs, including HuR, in breast cancer progression and DNA damage response and iii). explore RBPs with emphasis on HuR as therapeutic target for breast cancer therapy.
over 3 years ago
Review • Journal
|
HNRNPD (Heterogeneous Nuclear Ribonucleoprotein D) • RBM38 (RNA Binding Motif Protein 38) • RBM24 (RNA Binding Motif Protein 24)
In summary, this is the first report describing the occurrence of ocular toxicity induced by pertuzumab in the Chinese population and exploring the possible genetic mechanisms. These findings could provide evidence for clinicians to raise concerns about the risk of ocular toxicity with the clinical use of pertuzumab.
over 3 years ago
Journal
|
mTOR (Mechanistic target of rapamycin kinase) • IRS2 (Insulin receptor substrate 2) • CDH23 (Cadherin Related 23) • RBM24 (RNA Binding Motif Protein 24)